The Lagos state government has set up a medical team to review the circumstances surrounding the death of Akwa Ibom State Commissioner of Police, Mr. Waheed Ayilara within seven days.
Ayilara died at the Lagos State University Teaching Hospital (LASUTH) on Thursday, August 29, 2024.
In a statement on Saturday, the state’s commissioner for health, Prof. Akin Abayomi, commiserated with the deceased family, the cause of death will be investigated.
“In the light of the circumstances surrounding his passing, happening some hours after an apparently uneventful surgery, the Ministry of Health, following a directive from Mr Governor, has constituted a medical panel to review the clinical circumstances leading to the death.
“This panel is headed by the Chief Medical Director of LASUTH, Prof Adetokunbo Fabanwo. It will submit a comprehensive report on the matter in 7 days,” he said.
He assured that the state government will thoroughly unearth the cause to restore confidence to the public.
“We share the grief – and understand the anxiety – that this news may have caused and we assure the public that the Lagos State Government is committed to ensuring a thorough investigation.”
“Once again, we commiserate with the family of the late Mr. Ayilara, the Police and the Government and people of Akwa Ibom State. Our thoughts and prayers are with you during this time of sorrow. May The Almighty give you the strength to go through this sorrowful time and bless the soul of Commissioner of Police Waheed Ayilara,” he said.
In a heated response, the Minister of the Federal Capital Territory (FCT), Nyesom Wike, has…
President Bola Tinubu, on Thursday, approved the appointment of three Nigerians as directors-general of various agencies…
The Edo State chapter of the Peoples Democratic Party (PDP) has expressed deep disappointment and anger over…
The body of the late Chief of Army Staff, Lieutenant General Taoreed Lagbaja, has arrived…
The federal government has unveiled a proposed budget of N47.9 trillion for the 2025 fiscal…
The WHO defines counterfeit drugs as those deliberately mislabeled to deceive consumers about their identity…